BIOCON
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Biocon along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.82₹ -6.65
As on Sep 15, 2025, 4:01 PM IST
Biocon Price Performance
Today's LowToday's High
₹357.05₹368.05
₹358.45
52 Weeks' Low52 Weeks' High
₹290.80₹405.90
₹358.45
Open Price
₹367.00
Prev. Close
₹365.10
Volume
71,995
Over the last 5 years, the share price of Biocon has declined 3.58% CAGR. Over the past year, the corresponding return has been -5.37%.
Biocon’s current P/E of 124.48x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Biocon Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Biocon | -1.47 | -0.49 | 0.84 | 11.01 | -5.37 | 5.74 | -3.58 |
| Sun Pharmaceutical Industries | 0.49 | -2.26 | -5.11 | -4.83 | -13.57 | 21.68 | 26.44 |
| Divi's Laboratories | 0.52 | -1.02 | -9.43 | 7.50 | 9.92 | 18.00 | 13.79 |
| Cipla | -0.28 | -0.82 | 2.90 | 5.98 | -6.64 | 13.52 | 16.50 |
| Torrent Pharmaceuticals | -1.37 | -2.40 | 8.62 | 15.45 | 2.18 | 32.67 | 20.35 |
| Dr. Reddy's Laboratories | 2.63 | 3.94 | -4.38 | 17.51 | -2.24 | 15.26 | 8.32 |
| Mankind Pharma | 1.08 | 4.60 | 8.27 | 17.17 | 3.21 | 21.89 | 12.61 |
| Zydus Lifesciences | 2.11 | 4.70 | 6.21 | 17.34 | -7.42 | 40.21 | 22.95 |
| Lupin | 5.05 | 2.70 | 2.13 | 3.75 | -9.35 | 44.73 | 16.11 |
| Abbott India | -0.65 | -6.10 | -1.81 | 4.61 | 4.78 | 19.99 | 13.39 |
| Alkem Laboratories | 2.90 | 1.86 | 13.26 | 16.73 | -13.69 | 19.58 | 13.54 |
| Aurobindo Pharma | 5.14 | 1.94 | -4.57 | 0.31 | -29.95 | 25.70 | 6.66 |
| Glenmark Pharmaceuticals | 2.18 | 3.28 | 25.67 | 49.43 | 19.74 | 74.71 | 34.18 |
| Laurus Labs | 1.69 | 3.76 | 34.34 | 56.24 | 77.17 | 17.47 | 27.44 |
| Anthem Biosciences | 0.51 | 10.51 | 14.19 | 14.19 | 14.19 | 4.52 | 2.69 |
| GlaxoSmithKline Pharmaceuticals | -0.66 | -0.78 | -16.58 | 3.56 | -5.20 | 24.76 | 9.75 |
| Cohance Lifesciences | 6.06 | -0.70 | -2.47 | -14.48 | -18.86 | 26.63 | 21.97 |
| Ipca Laboratories | -1.64 | -3.72 | -3.93 | 1.15 | -11.03 | 13.54 | 4.09 |
| Gland Pharma | 5.95 | 2.86 | 18.75 | 29.08 | 6.84 | -6.26 | 1.96 |
| Ajanta Pharma | -2.38 | -4.41 | -3.23 | 0.37 | -23.39 | 22.22 | 20.19 |
Over the last one year, Biocon has declined 5.37% compared to peers like Sun Pharmaceutical Industries (-13.57%), Divi's Laboratories (9.92%), Cipla (-6.64%). From a 5 year perspective, Biocon has underperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Biocon Financials
Biocon Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 364.1 | 363.77 |
| 10 | 359.58 | 362.2 |
| 20 | 359.58 | 362.2 |
| 50 | 371.64 | 363.22 |
| 100 | 355.21 | 359.15 |
| 200 | 353.9 | 351.76 |
Biocon Share Holding Pattern
In the latest quarter, Biocon remained same as its previous close in promoter holding, while DII stake increased to 22.83%, FII holding fell to 6.04%, and public shareholding moved down to 16.51% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Biocon Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| SBI Contra Fund | 2,88,07,465 | 2.15 | 1,003.51 |
| SBI Magnum Midcap Fund | 1,39,69,697 | 2.21 | 486.63 |
| Kotak Equity Opportunities Fund - Regular Plan | 1,30,00,000 | 1.64 | 452.86 |
| SBI Balanced Advantage Fund | 1,00,21,205 | 0.95 | 349.09 |
| Nippon India Multi Cap Fund | 77,84,554 | 0.59 | 271.17 |
| Nippon India Focused Equity Fund | 72,99,915 | 3.02 | 254.29 |
| Franklin India Prima Fund | 58,62,280 | 1.83 | 229.45 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 56,80,217 | 3.21 | 197.87 |
| HSBC Midcap Fund | 49,89,071 | 1.48 | 173.79 |
| Kotak Equity Arbitrage Fund - Regular Plan | 44,40,000 | 0.21 | 154.67 |
Biocon Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Biocon Options
Biocon Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 13, 2025, 11:49 PM IST | Biocon - Letters To Shareholders Under 100 Days Campaign - 'Saksham Niveshak' |
| Sep 12, 2025, 11:03 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 11, 2025, 5:57 AM IST | Biocon - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 11, 2025, 1:44 AM IST | Biocon - Email Communication To Shareholders Under 100 Days Campaign - 'Saksham Niveshak' |
| Sep 10, 2025, 1:43 AM IST | Biocon - Announcement under Regulation 30 (LODR)-Change in Management |
About Biocon
Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2242.60 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address20th K.M. Hosur Road, Electronics City, Bengaluru Karnataka 560100
- Contact
Management
- Ms. Kiran Mazumdar ShawExecutive Chairperson
- Mr. Siddharth MittalManaging Director & CEO
- Prof. Ravi Rasendra MazumdarNon Exe.Non Ind.Director
- Mr. Eric Vivek MazumdarNon Exe.Non Ind.Director
- Mr. Bobby Kanubhai ParikhIndependent Director
- Mr. Naina Lal KidwaiLead Independent Director
- Ms. Rekha Mehrotra MenonIndependent Director
- Mr. Nicholas Robert HaggarIndependent Director
- Mr. Atul DhawanIndependent Director
FAQs on Biocon Share Price
What is the share price of Biocon?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biocon is ₹358.45 as on Sep 15, 2025.
What kind of stock is Biocon?
The Biocon is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Biocon?
The market cap of Biocon is ₹47,923.46 Cr as on Sep 15, 2025.
What are today's High and Low prices of Biocon?
Today’s highest and lowest price of Biocon are ₹368.05 and ₹357.05.
What are the 52 Week High and 52 Week Low of Biocon?
The 52-week high/low is the highest and lowest price at which Biocon stock has traded in the past 52-week or nearly a year. The 52-week high of Biocon is ₹405.90 and 52-week low of Biocon is ₹290.80 as on Sep 15, 2025.
How has the Biocon performed historically in terms of returns?
The Biocon has shown returns of -1.82% over the past day, -0.49% for the past month, 0.84% over 3 months, -5.37% over 1 year, 5.74% across 3 years, and -3.58% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Biocon?
P/E ratio of and PB ratio of Biocon are 124.48 and 2.28 on Sep 15, 2025. While the company gives a dividend yield of 0.14 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data